I did confirm with a high level executive at AbbVi

Quote:

---

I did confirm with a high level executive at AbbVie that a small bio's 'SHAREPRICE" has little effect on a BP's decision to partner or price or offer. Now please note the conversation was very indepth and went in many directions, so one of the topics was the question of how many drugs, or how many indications per drug, or what type of indication, is it unmet medical need, etc... How many CDA's? The discussion went on and covered a whole bunch of topics but as I explained IPIX, and he understood the company...he expressed that if IPIX is smart they move diligently and stealth - light footed I think he said while the mix of BP's - BIO's sort through the process and offers and paperwork. it takes time and sometimes alot of time. But, IPIX has had CDA's for quite some time and have been talking about it for years so I think we are close IMO. BP goes in with the understanding of market potential including competitors and risk. For B-OM - it really is SKY HIGH - wild wild west...... Alot of money to be made in the GOLD RUSH era and we are dead smack in the middle. Prurisol could also be that with it being a previously approved drug and very safe and ORAL.

---

Good stuff, Daubers. Patience is all that is required. The bottom may slowly continue to drop until we get a deal in place but I have confidence that ever share of CTIX/IPIX that has ever been purchased and held will become profitable in time. Whether it happens over a year, a decade or in one night with a gap up to new highs is anyone's guess.

Go IPIX!

All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.